S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
All the trading advice you’ve ever received boils down to this (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Vicapsys Life Sciences Stock Price, News & Analysis (OTCMKTS:VICP)

$2.75
0.00 (0.00%)
(As of 12/1/2023 ET)
Compare
Today's Range
$2.75
▼
$2.75
50-Day Range
$1.00
▼
$3.00
52-Week Range
$1.03
▼
$3.00
Volume
N/A
Average Volume
12 shs
Market Capitalization
$88.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC Filings

VICP stock logo

About Vicapsys Life Sciences Stock (OTCMKTS:VICP)

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Cumming, Georgia.

VICP Stock Price History

VICP Stock News Headlines

November 4, 2023 | morningstar.com
Anavex Life Sciences Corp AVXL
August 9, 2023 | finance.yahoo.com
VICP - Vicapsys Life Sciences, Inc.
December 3, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
July 3, 2023 | msn.com
ViCapsys files for Nasdaq uplisting, $8M public offering
February 19, 2023 | benzinga.com
Global Life Science Tools Strategic Business Report 2023: Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects
September 29, 2022 | finance.yahoo.com
ViCapsys Life Sciences Appoints Three New Board Members
April 18, 2022 | finance.yahoo.com
ViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive Officer
See More Headlines
Receive VICP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VICP
CUSIP
N/A
CIK
1468639
Web
vicapsys.com
Phone
(972) 891-8033
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-990,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-598.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.04) per share
Price / Book
-68.75

Miscellaneous

Outstanding Shares
32,071,000
Free Float
30,153,000
Market Cap
$88.20 million
Optionable
Not Optionable
Beta
-5.17
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Federico Pier (Age 55)
    CEO, Executive Chairman & Interim President
    Comp: $120k
  • Mr. Jeffery Wright CPA (Age 40)
    CPA, Chief Financial Officer
    Comp: $90k
  • Dr. Mark C. Poznansky M.D.
    Ph.D., Chief Scientist Advisor & Founder

Key Competitors

View All Competitors














VICP Stock Analysis - Frequently Asked Questions

How have VICP shares performed in 2023?

Vicapsys Life Sciences' stock was trading at $1.00 at the beginning of the year. Since then, VICP stock has increased by 175.0% and is now trading at $2.75.
View the best growth stocks for 2023 here.

How were Vicapsys Life Sciences' earnings last quarter?

Vicapsys Life Sciences, Inc. (OTCMKTS:VICP) released its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter.

How do I buy shares of Vicapsys Life Sciences?

Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:VICP) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -